# Abscopal Effect for Metastatic Non-small Cell Lung Cancer.

> **NCT02542930** · PHASE2 · WITHDRAWN · sponsor: **Zhejiang Provincial People's Hospital**

## Conditions studied

- Non-small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer
- Radiotherapy
- Thymalfasin

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** Thymalfasin

## Key facts

- **NCT ID:** NCT02542930
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No recruitment.
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542930, "Abscopal Effect for Metastatic Non-small Cell Lung Cancer.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02542930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*